Global Theragnostic Nuclear Medicine Market Estimation For 2025

Use of precision or targeted nuclear medicines has seen rapid growth, especially in oncology, over the last 5 years.  Understanding this market segment is crucial for investment and management decisions. Total Addressable Market (TAM) estimate for precision radiodiagnostics and radiotherapeutics is discussed in detail in this report. Based on the public information and logical assessments in the absence of public information,  global market size of nuclear medicines reached USD 12.5B in 2025, with radiodiagnostics share of about 75%. This report is ideal for business, sales as well as investment professionals for market insight into the rapidly growing nuclear medicines sector.